Published in Rheumatology (Oxford) on December 07, 2012
Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis (2014) 2.05
Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study. Rheumatology (Oxford) (2013) 1.11
Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network. Pharmacoepidemiol Drug Saf (2014) 1.04
Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden--a population-based register study. PLoS One (2014) 1.02
Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom. JAMA Dermatol (2015) 1.00
Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence. Curr Rheumatol Rep (2015) 0.89
Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set. RMD Open (2016) 0.88
Psoriasis in the US Medicare Population: Prevalence, Treatment, and Factors Associated with Biologic Use. J Invest Dermatol (2015) 0.85
The Epidemiology of Psoriatic Arthritis. Rheum Dis Clin North Am (2015) 0.83
Prevalence of psoriatic arthritis and costs generated by treatment of psoriatic arthritis patients in the public health system - the case of Poland. Reumatologia (2016) 0.75
Identifying a novel locus for psoriatic arthritis. Rheumatology (Oxford) (2015) 0.75
Psoriasis and psoriatic arthritis in African-American patients--the need to measure disease burden. Clin Rheumatol (2014) 0.75
Important Treatment Outcomes for Patients with Psoriatic Arthritis: A Multisite Qualitative Study. Patient (2017) 0.75
The association between sonographic enthesitis and radiographic damage in psoriatic arthritis. Arthritis Res Ther (2017) 0.75
Clinical features and types of articular involvement in patients with psoriatic arthritis. Clin Rheumatol (2014) 0.75
The Read clinical classification. BMJ (1990) 15.83
Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract (2010) 7.41
The General Practice Research Database: quality of morbidity data. Popul Trends (1997) 7.07
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf (2007) 5.93
Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis (2005) 4.67
The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol (2000) 3.62
The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf (2005) 3.24
Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol (2005) 3.04
Psoriatic arthritis (PSA)--an analysis of 220 patients. Q J Med (1987) 2.80
Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum (2009) 2.06
The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum (2009) 1.84
Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol (2010) 1.80
Validity of The Health Improvement Network (THIN) for the study of psoriasis. Br J Dermatol (2011) 1.78
Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol (2009) 1.49
Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol (2003) 1.48
Does feedback improve the quality of computerized medical records in primary care? J Am Med Inform Assoc (2002) 1.45
Psoriatic arthritis in psoriatic patients. Br J Rheumatol (1984) 1.40
Psoriatic arthritis: interrelationships between skin and joint manifestations related to onset, course and distribution. Clin Rheumatol (2000) 1.15
Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol (2005) 1.12
Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: A systematic and critical review. BMC Med Res Methodol (2011) 1.12
Clinical and radiological damage in psoriatic arthritis. Ann Rheum Dis (2005) 1.07
Guideline for anti-TNF-alpha therapy in psoriatic arthritis. Rheumatology (Oxford) (2005) 1.05
Psoriatic arthritis in Reykjavik, Iceland: prevalence, demographics, and disease course. J Rheumatol (2007) 1.02
Epidemiology of psoriatic arthritis in northwest Greece, 1982-2001. J Rheumatol (2003) 1.01
Psoriatic arthritis epidemiology. Curr Rheumatol Rep (2007) 0.99
Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices. J Dermatolog Treat (2006) 0.94
Incidence of arthritis in a prospective cohort of psoriasis patients. Arthritis Care Res (Hoboken) (2011) 0.93
Psoriasis and systemic inflammation: underdiagnosed enthesopathy. J Eur Acad Dermatol Venereol (2009) 0.89
Identification of risk factors for psoriatic arthritis: scientific opportunity meets clinical need. Arch Dermatol (2010) 0.89
Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study. Rheumatology (Oxford) (2010) 0.87
Juvenile psoriatic arthritis: bathwater or baby? J Rheumatol (2009) 0.84
Review of clinical registries of psoriatic arthritis: lessons learned?: value for the future? Curr Rheumatol Rep (2011) 0.83
Case definition of psoriatic arthritis. Lancet (2000) 0.83
Regional review of patients with psoriatic arthritis in secondary care in the West Midlands: prevalence, disease activity and eligibility for anti-tumour necrosis factor therapy. Clin Exp Rheumatol (2010) 0.78
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum (2008) 19.80
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest (2003) 16.67
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum (2011) 6.28
2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) (2012) 5.22
American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis (2011) 4.15
Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol (2006) 4.12
Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J (2009) 3.93
Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med (2009) 3.33
Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ (2013) 3.22
Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial. Ann Intern Med (2012) 3.14
Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process. J Invest Dermatol (2010) 3.09
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04
The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004. J Am Acad Dermatol (2008) 2.95
The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol (2010) 2.90
2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) (2012) 2.83
Innate immunity modulates adipokines in humans. J Clin Endocrinol Metab (2007) 2.48
Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol (2011) 2.36
National Psoriasis Foundation clinical consensus on disease severity. Arch Dermatol (2007) 2.29
Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol (2010) 2.29
Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol (2008) 2.25
National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol (2008) 2.19
Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology (2005) 2.15
Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum (2012) 2.15
Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics (2012) 2.04
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol (2011) 2.03
Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med (2011) 1.94
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol (2009) 1.94
Phase II trial of pleural photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread. J Clin Oncol (2004) 1.93
Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. JAMA Dermatol (2013) 1.88
Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. Arch Dermatol (2011) 1.88
Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Res Ther (2006) 1.80
Immunosuppressant medications and mortality in inflammatory bowel disease. Am J Gastroenterol (2008) 1.80
Purine-rich foods intake and recurrent gout attacks. Ann Rheum Dis (2012) 1.79
Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol (2005) 1.79
Physician attitudes toward regionalization of adult critical care: a national survey. Crit Care Med (2009) 1.79
Plasma uric acid level and risk for incident hypertension among men. J Am Soc Nephrol (2006) 1.76
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol (2009) 1.76
Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes. Diabetes Care (2009) 1.75
Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study. J Natl Cancer Inst (2012) 1.69
Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification. Arterioscler Thromb Vasc Biol (2010) 1.69
Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. J Natl Cancer Inst (2003) 1.68
Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol (2013) 1.64
Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients. J Invest Dermatol (2007) 1.64
Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis (2012) 1.63
A genome-wide association study identifies LIPA as a susceptibility gene for coronary artery disease. Circ Cardiovasc Genet (2011) 1.63
Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection. Pharmacoepidemiol Drug Saf (2009) 1.61
The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials. J Am Acad Dermatol (2011) 1.59
AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol (2008) 1.54
Adipokines, insulin resistance, and coronary artery calcification. J Am Coll Cardiol (2008) 1.53
Racial differences in quality of life following prostate cancer diagnosis. Urology (2010) 1.51
Major cardiovascular events associated with anti-IL 12/23 agents: a tale of two meta-analyses. J Am Acad Dermatol (2013) 1.49
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol (2009) 1.48
Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship. Infect Control Hosp Epidemiol (2014) 1.45
Fractalkine is a novel human adipochemokine associated with type 2 diabetes. Diabetes (2011) 1.44
Antibiotic exposure and the risk for depression, anxiety, or psychosis: a nested case-control study. J Clin Psychiatry (2015) 1.43
Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort. Arthritis Rheum (2010) 1.42
Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy (2012) 1.41
Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am J Med (2010) 1.39
Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis. Arch Dermatol (2012) 1.37
From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis. J Am Acad Dermatol (2007) 1.35
Gene profiling of human adipose tissue during evoked inflammation in vivo. Diabetes (2009) 1.34
Phosphatase-resistant gap junctions inhibit pathological remodeling and prevent arrhythmias. Circ Res (2011) 1.32
Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems. Pharmacoepidemiol Drug Saf (2011) 1.30
Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis. Atherosclerosis (2012) 1.29
Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database. Pharmacoepidemiol Drug Saf (2013) 1.23
Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis. J Am Acad Dermatol (2012) 1.21
Uric acid and insulin sensitivity and risk of incident hypertension. Arch Intern Med (2009) 1.21
Properties of the Arg376 residue of the proton-coupled folate transporter (PCFT-SLC46A1) and a glutamine mutant causing hereditary folate malabsorption. Am J Physiol Cell Physiol (2010) 1.20
A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis. Clin Cancer Res (2006) 1.19
Dermatologist preferences for first-line therapy of moderate to severe psoriasis in healthy adult patients. J Am Acad Dermatol (2011) 1.18
Inflammation modulates human HDL composition and function in vivo. Atherosclerosis (2012) 1.18
Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. J Allergy Clin Immunol (2013) 1.17
Gout and the risk of Parkinson's disease: a cohort study. Arthritis Rheum (2008) 1.16
Vitiligo-like hypopigmentation associated with imiquimod treatment of genital warts. J Am Acad Dermatol (2005) 1.16
Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study. Rheumatology (Oxford) (2013) 1.11
Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution? Infect Control Hosp Epidemiol (2008) 1.11
Validation of The Health Improvement Network (THIN) database for epidemiologic studies of chronic kidney disease. Pharmacoepidemiol Drug Saf (2011) 1.11
Race and gender variation in response to evoked inflammation. J Transl Med (2013) 1.10
Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study. Ann Rheum Dis (2012) 1.08
Fructose and vitamin C intake do not influence risk for developing hypertension. J Am Soc Nephrol (2009) 1.08
Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms. Obstet Gynecol (2008) 1.07
Effectiveness of academic detailing on breast cancer screening among primary care physicians in an underserved community. J Am Board Fam Med (2006) 1.07
Consensus guidelines for the management of plaque psoriasis. Arch Dermatol (2012) 1.06
Diagnostic E-codes for commonly used, narrow therapeutic index medications poorly predict adverse drug events. J Clin Epidemiol (2008) 1.05
Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation. J Acquir Immune Defic Syndr (2015) 1.05
Update on the epidemiology and systemic treatment of psoriasis. Expert Rev Clin Immunol (2007) 1.05
Relation of plasma fatty acid binding proteins 4 and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with type-2 diabetes mellitus. Am J Cardiol (2010) 1.05
Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network. Pharmacoepidemiol Drug Saf (2014) 1.04
Metformin and survival in pancreatic cancer: a retrospective cohort study. Pancreas (2013) 1.03
Implementing academic detailing for breast cancer screening in underserved communities. Implement Sci (2007) 1.03
Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites. Diabetes (2009) 1.02
Pure mucinous carcinoma of the breast. Am J Surg (2004) 1.01